NASDAQ Companies

SAN DIEGO, Sept. 04, 2020 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the […]

INDIANAPOLIS, Sept. 04, 2020 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the third fiscal quarter […]

SAN DIEGO, Sept. 04, 2020 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on […]

SAN JOSE, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) […]

BOSTON, Sept. 04, 2020 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) today announced that Jason Robins, co-founder, Chief Executive Officer […]

COPENHAGEN, Denmark, Sept. 04, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative […]

CAMBRIDGE, Mass., Sept. 04, 2020 (GLOBE NEWSWIRE) — Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company focused on the […]

NEW HAVEN, Conn., Sept. 04, 2020 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new […]

SOUTH SAN FRANCISCO, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused […]

WOBURN, Mass., Sept. 04, 2020 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it will present a scientific poster […]